COVERAGE
Market Reacts to Trump Move to Revoke AI Safety, Security Standards
January 22, 2025
Read time: 2 min

COVERAGE
January 22, 2025
Read time: 2 min

COVERAGE
January 21, 2025
Read time: 2 min

COVERAGE
January 21, 2025
Read time: 2 min

PRESS RELEASE
January 21, 2025
Read time: 4 min
International law firm McDermott Will & Emery welcomes Jayme Cassidy as its new transactions pro bono counsel in Miami. Jayme brings extensive experience and a deep commitment to pro bono work, having previously served in various leadership roles at prominent legal aid organizations.
“We’re thrilled to welcome Jayme to our team,” said Paul Thompson, McDermott’s pro bono litigation partner. “Her extensive background in legal advocacy, dedication to promoting access to justice, and passion for pro bono work align perfectly with our commitment to giving back to the community.” “We look forward to working with Jayme to further expand our pro bono initiatives and to help us continue to make a meaningful impact,” said Elizabeth Lewis, the Firm’s pro bono and community service partner.
As the Transactions Pro Bono Counsel, Jayme will be responsible for expanding the Firm’s pro bono efforts outside of litigation, working to developing new initiatives supporting small businesses, low-income entrepreneurs, nonprofits and nongovernmental organizations (NGOs) in underserved communities around the globe and engaging lawyers in our transactions, tax, private client and health practice groups.
Jayme joins from the National Institute for Trial Advocacy (NITA), where she promoted the development of legal skills nationwide for nonprofit advocates and law firm lawyers. Prior to NITA, Jayme served as the executive director of the Pennsylvania Legal Aid Network and the chief diversity, equity, inclusion, pro bono and professional development officer of Legal Services of Greater Miami (LSGMI). While at LSGMI, Jayme developed its innovative transactional pro bono program, which brings lawyers from law firms and in-house legal departments together to serve small businesses in their communities.
Jayme also serves as a leader in pro bono and legal aid nationally, sitting on the American Bar Association (ABA) Standing Committee on Legal Aid and Indigent Defense and chairing the ABA Business Law Section’s Committee on Pro Bono.
“I’m honored to join McDermott and contribute to its outstanding pro bono program,” said Jayme. “I can’t wait to collaborate with my new colleagues to further our shared mission of providing high-quality legal services to underserved communities.”
McDermott’s pro bono program is focused on providing legal services to displaced persons around the world; fighting wrongful convictions; and supporting nonprofits, small businesses, and entrepreneurs from traditionally marginalized communities globally. In 2024 alone, the Firm volunteered more than 80,000 hours and achieved a remarkable 95% participation rate among its US lawyers.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers, and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

PRESS RELEASE
January 21, 2025
Read time: 5 min
International law firm McDermott Will & Emery is pleased to announce the appointment of new leaders for its global Antitrust Practice Group. The Firm’s international antitrust lawyers provide effective, coordinated counsel on antitrust and competition laws across all sectors of the economy, including healthcare and life sciences; food and beverage; technology; building materials; aerospace and defense; and other industries.
The leadership group now consists of:
“I’m pleased to have Ryan, Jon, and Christian leading our preeminent global Antitrust Practice Group, and we thank our partner, Ray Jacobsen, for his many contributions in leading practice over the years and look forward to continuing to work with Ray as a key member of our team,” said Alva Mather, global head of McDermott’s Regulatory Practice Group. “We counsel clients throughout the entire lifecycle of transactions, and we are well positioned for the anticipated upswing in M&A activity in 2025. We’re prioritizing growth and remain committed to bringing top-notch practitioners in M&A, antitrust litigation, and investigations to serve our clients.”
ABOUT McDERMOTT’S ANTITRUST PRACTICE GROUP
McDermott delivers regulatory and compliance acumen in a number of key areas, including antitrust and competition, alcohol regulatory, government contracts, government and lobbying strategies, international trade, and privacy and cybersecurity. More than 100 lawyers strong, with team members based in the US and Europe, the Regulatory Practice Group is recognized globally in Chambers, Legal 500, and Best Law Firms. Recognized as a global leader in competition law, our antitrust practice is ranked among the top 25 firms in the GCR 100: Global Elite Rankings. Chambers notes of our interdisciplinary regulatory practice that “the nuance of the team’s knowledge on specific areas is impressive” and “the client service is excellent, responsive, and importantly, practical.” With international reach, we give companies across sectors and jurisdictions a leg up on evaluating and navigating risk and turning potential liabilities into business opportunities.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

DEAL ANNOUNCEMENT / PRESS RELEASE
January 21, 2025
Read time: 3 min
Munich, January 21, 2025 – With a team led by Holger Ebersberger and Thomas Diekmann, McDermott Will & Emery advised NORD Holding on the acquisition of HKS health solutions GmbH (HKS). McDermott also advised on the financing of the acquisition, with the Private Equity Finance team led by Matthias Weissinger.
The acquisition of HKS is part of the formation of 1Q Health Group, which – following the acquisition of ABJ alive GmbH in 2024 – continues NORD Holding’s European buy-and-build strategy in the market for high-quality dietary supplements and pharmaceuticals. The HKS founders, Benjamin Hawlik, Markus Koisser and Dirk Sachon, will reinvest and remain active as management board members.
HKS, created in 2021 through the merger of three specialized companies, is active in the areas of contract manufacturing of high-quality dietary supplements and pharmaceuticals, trading in more than 1,500 raw materials, and distribution of private labels under the umbrella brand HAWLIK.
NORD Holding is a private equity and asset management company with assets under management of around EUR 4 billion. The focus of NORD Holding’s direct business is on the structuring and financing of corporate succession models, the acquisition of parts of groups/subsidiaries and the expansion financing of medium-sized companies. The fund investment division focuses on the micro and small cap segment of medium-sized European private equity funds.
McDermott advised NORD Holding already on the acquisition of ABJ alive.
The McDermott team was led by Holger Ebersberger, Thomas Diekmann, and Matthias Weissinger, and included Julia Külzer, Parsin Walsi, Alexandra Prato, Franziska Sauer, Tim Becker, Florian Schiefer, Carina Kant, Jana Grieb, Christian Lebrecht, Lea Hachmeister, Christian Rolf, Janek Joosten, Steffen Woitz, Claus Färber, Ettore Scandale, and Emma Greselin.

DEAL ANNOUNCEMENT / PRESS RELEASE
January 21, 2025
Read time: 3 min
Frankfurt, January 21, 2025 – McDermott Will & Emery advised Eurazeo Global Investor as lender in the refinancing of The Relevance Group (TRG).
The Relevance Group is a European group of companies founded in Hamburg in 2022. With more than 290 experts in Germany, Switzerland and the Netherlands TRG offers solutions in the field of data-driven sales and marketing optimization.
Since its foundation as a buy-and-build platform through Ufenau Capital Partners’ acquisition of Datalogue GmbH, TRG has successfully integrated six additional companies into its portfolio, significantly strengthening the Group’s sales power and service portfolio. TRG now plans to expand into Central and Eastern Europe, Scandinavia and the Iberian Peninsula.
TRG is part of the portfolio of the Ufenau VII German Asset Light, SLP fund of the Swiss investor group Ufenau Capital Partners. Since 2011, Ufenau has invested in more than 380 service companies in Europe, and has around €3 billion in assets under management.
Eurazeo is a global investment company with €35.5 billion in assets under management, invested in more than 600 companies. The firm is listed on Euronext Paris and runs offices in Paris, New York, London, Frankfurt, Berlin, Milan, Madrid, Luxembourg, Shanghai, Seoul, Singapore and Sao Paulo.
McDermott has previously advised Eurazeo as a lender in several financing projects, such as the financing of an acquisition of shares in the management consultancy UNITY AG by Deutsche Beteiligungs AG (DBAG) and the financing of the AOE Group.
The McDermott team was led by partner Alexander Klein and included partner Matthias Weissinger and associate Michael Spirk.

COVERAGE
January 20, 2025
Read time: 2 min

DEAL ANNOUNCEMENT
January 17, 2025
Read time: 3 min
McDermott Will & Emery represented Apollo Care, a rapidly growing provider of patient access and commercial solutions to the healthcare industry, in its investment from Flexpoint Ford, a private equity investment firm that specializes in privately negotiated investments in the healthcare and financial services industries.
The McDermott team was led by Krist Werling and John Zukin and included Marisa Montoya, Kevin Hall, Kate Vera, Kelly Holloway and Jennifer Mikulina.
Read Flexpoint Ford’s press release.
With more than 150 private equity-focused lawyers working across offices globally, McDermott’s Private Equity Group is poised to help clients stay ahead of the curve on all types of PE transactions, including fund formation, mergers and acquisitions, minority and majority investments, and leveraged buyouts. Legal 500 notes our team’s “ability to understand the business and specific needs of the client.” We anticipate the unknown and deliver actionable solutions, aligning our strategy and advice with clients’ objectives and guiding them through each step of the private equity life cycle. At every stage, we manage and assess risks and opportunities while looking for the most efficient way to get the deal done. Our team of leading private equity practitioners offers deep industry experience in the healthcare, life sciences, food and beverage, energy, real estate, insurance, and technology sectors – along with the cross-border and cross-practice capabilities critical to facilitating business success.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

COVERAGE
January 17, 2025
Read time: 2 min